Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
18056 Yukon Inc. is a Canadian investment holding company that served as a primary vehicle for the life sciences investments of biotech entrepreneur Dr. Francesco Bellini. The company is best known for its role as a major shareholder in Picchio Pharma Inc., a joint venture with Power Technology Investment Corporation that held significant stakes in Neurochem Inc. (later BELLUS Health). Through its strategic holdings, 18056 Yukon Inc. was instrumental in the early-stage financing and corporate governance of companies developing treatments for Alzheimer's disease and other neurological conditions. The company was headquartered in Whitehorse, Yukon, and was involved in several high-profile share transfers and corporate restructurings within the Bellini group of companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 18056 Yukon.